Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| BCAP-XHEALTH | TGENOME | |
|---|---|---|
| Held by both | ||
| 1.92% | 8.90% | |
| 1.87% | 7.84% | |
| 1.66% | 6.99% | |
| Only in BCAP-XHEALTH | ||
| 2.03% | N/A | |
| 1.62% | N/A | |
| 1.37% | N/A | |
| 1.33% | N/A | |
| Only in TGENOME | ||
| N/A | 4.10% | |
| N/A | 3.96% | |
| N/A | 3.92% | |
| Personalis | N/A | 3.82% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TGENOME | +63.50% | 40.04% | 1.59 |
| BCAP-XHEALTH | +20.73% | 19.58% | 1.06 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | BCAP-XHEALTH | TGENOME |
|---|---|---|
Fund details | ||
| Fund size | 472 million | 1,372 million |
| Inception date | 14 May 2021 | 13 Jan 2021 |
| Master fund | กองทุนที่ลงทุนหลายกอง | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 84.93% |
Minimum purchase and redemption | ||
| First purchase | 500 THB | 1,000 THB |
| Subsequent purchase | 500 THB | 1,000 THB |
| Redemption (amount) | No minimum | No minimum |
| Redemption (units) | No minimum | No minimum |
| Balance (amount) | No minimum | No minimum |
| Balance (units) | No minimum | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:30 | 15:30 |
| Redeem before | 15:30 | 15:30 |
| Redemption paid | T+3 | T+3 |